Welcome to our dedicated page for Morgan Stanley SEC filings (Ticker: MS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Morgan Stanley filings document the company’s financial services business, capital structure, governance and material events. The record includes 8-K reports for current events, proxy materials for annual meeting and shareholder voting matters, and securities listings covering common stock, depositary preferred shares and medium-term notes associated with Morgan Stanley Finance LLC.
Filings also disclose governance procedures, registered security classes, NYSE listing information, preferred stock series, debt-security registration matters and formal status changes such as a Form 25 notice for removal of a listed note class from exchange registration.
Morgan Stanley Finance LLC is offering Buffered PLUS—principal-at-risk structured notes—due 3 August 2028, linked to the Dow Jones Industrial Average (INDU), S&P 500 (SPX) and Russell 2000 (RTY). Each $1,000 note delivers no periodic interest and is an unsecured obligation of MSFL, fully guaranteed by Morgan Stanley.
Pay-off mechanics rely on the worst-performing underlier on the single observation date (31 July 2028):
- If every index closes above its initial level, the investor receives principal + leveraged upside: $1,000 × [1 + (163%–173%) × % gain of the worst performer].
- If any index finishes at or below its initial but at or above 90 % of it, only par ($1,000) is returned.
- If any index closes below 90 % of its initial level, repayment equals principal × (performance factor + 10 %), imposing a 1 : 1 loss beyond the 10 % buffer, subject to a minimum redemption of $100 (10 %).
Key terms
- Issue price: $1,000; estimated value at pricing: ≈ $962.10 (reflects embedded issuance, structuring and hedging costs).
- Leverage factor: to be fixed at 163 %–173 % on 31 July 2025 strike/pricing date.
- Buffer: 10 % downside protection on each index.
- Distribution: sold through fee-based advisory accounts; dealers may earn up to $6.25/note structuring fee; MS &Co. will not receive a sales commission.
- Liquidity: not exchange-listed; secondary market, if any, made solely by MS &Co. at its discretion.
- CUSIP/ISIN: 61778NCZ2 / US61778NCZ24.
Principal risks highlighted by the issuer include:
- Exposure to credit risk of Morgan Stanley/MSFL; notes are unsecured and unsubordinated.
- No periodic income; return depends solely on terminal index performance.
- Concentration in worst-performing index negates diversification; a single index drop below buffer triggers losses.
- Market value likely below issue price after launch owing to embedded costs and use of an internal funding rate advantageous to the issuer.
- Limited liquidity and potential wide bid/offer spreads.
- Tax treatment uncertain; counsel expects prepaid financial contract, but IRS could disagree.
The product targets investors who are bullish to neutral on all three indices over a three-year horizon, can tolerate significant downside risk, and value a modest buffer alongside leveraged participation in capped equity upside.
Morgan Stanley Finance LLC is offering Buffered PLUS—principal-at-risk structured notes—due 3 August 2028, linked to the Dow Jones Industrial Average (INDU), S&P 500 (SPX) and Russell 2000 (RTY). Each $1,000 note delivers no periodic interest and is an unsecured obligation of MSFL, fully guaranteed by Morgan Stanley.
Pay-off mechanics rely on the worst-performing underlier on the single observation date (31 July 2028):
- If every index closes above its initial level, the investor receives principal + leveraged upside: $1,000 × [1 + (163%–173%) × % gain of the worst performer].
- If any index finishes at or below its initial but at or above 90 % of it, only par ($1,000) is returned.
- If any index closes below 90 % of its initial level, repayment equals principal × (performance factor + 10 %), imposing a 1 : 1 loss beyond the 10 % buffer, subject to a minimum redemption of $100 (10 %).
Key terms
- Issue price: $1,000; estimated value at pricing: ≈ $962.10 (reflects embedded issuance, structuring and hedging costs).
- Leverage factor: to be fixed at 163 %–173 % on 31 July 2025 strike/pricing date.
- Buffer: 10 % downside protection on each index.
- Distribution: sold through fee-based advisory accounts; dealers may earn up to $6.25/note structuring fee; MS &Co. will not receive a sales commission.
- Liquidity: not exchange-listed; secondary market, if any, made solely by MS &Co. at its discretion.
- CUSIP/ISIN: 61778NCZ2 / US61778NCZ24.
Principal risks highlighted by the issuer include:
- Exposure to credit risk of Morgan Stanley/MSFL; notes are unsecured and unsubordinated.
- No periodic income; return depends solely on terminal index performance.
- Concentration in worst-performing index negates diversification; a single index drop below buffer triggers losses.
- Market value likely below issue price after launch owing to embedded costs and use of an internal funding rate advantageous to the issuer.
- Limited liquidity and potential wide bid/offer spreads.
- Tax treatment uncertain; counsel expects prepaid financial contract, but IRS could disagree.
The product targets investors who are bullish to neutral on all three indices over a three-year horizon, can tolerate significant downside risk, and value a modest buffer alongside leveraged participation in capped equity upside.